Two recent studies considered whether initiation of second-line therapies in patients already taking metformin for type 2 diabetes occurs too soon or too late.
Two recent studies looked at the effects of diabetes on the brain, one focusing on mild cognitive impairment and the other on brain imaging findings.
Two studies compared heart failure rates in patients with and without type 2 diabetes, while a third looked at the risk of heart failure associated with various classes of glucose-lowering drugs.
Older patients with diabetes were the focus of several recent studies, including one that looked at associations between glycemic control and mortality and two that compared second-line medication options.
Studies published in July looked at factors and conditions associated with variation in glycemic control between clinic visits, including diabetes treatment intensity and Alzheimer's disease.
Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.
Recent studies looked at prevalence of diagnosed diabetes in the U.S.; trends in hospitalization for diabetic ketoacidosis; and the prevalence of obesity, metabolic syndrome, and diabetes.
Multiple recent studies focused on HIV and diabetes, looking at incidence of diabetes among patients with HIV, the effectiveness of medications in patients with both conditions, and efforts to improve nutrition in patients with one or both conditions
Recent studies looked at diabetic retinopathy's associations with age-related macular degeneration, chronic kidney disease, and different classes of diabetes drugs.
Two recent studies looked at the incidence of hypoglycemia among patients with diabetes around the world, while another offered an intervention to reduce hypoglycemia in patients with impaired awareness of it.